I've given up trying to figure out how biotechs will trade post approval, but I know its not worth holding a position when an FDA announcment is on the horizon.
The risk does not justify the reward in too many instances.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.